{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T20:06:25Z","timestamp":1695499585047},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10165-011-0542-4","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T14:48:46Z","timestamp":1319467726000},"page":"178-185","source":"Crossref","is-referenced-by-count":3,"title":["Beh\u00e7et\u2019s disease and genes within the major histocompatibility complex region"],"prefix":"10.1093","volume":"22","author":[{"given":"Yeong Wook","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,10,25]]},"reference":[{"key":"542_CR1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et\u2019s disease. N Engl J Med. 1999;341:1284\u201391.","journal-title":"N Engl J Med"},{"key":"542_CR2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/ard.59.8.622","volume":"59","author":"A G\u00fcl","year":"2000","unstructured":"G\u00fcl A, Inan\u00e7 M, Ocal L, Aral O, Koni\u00e7e M. Familial aggregation of Beh\u00e7et\u2019s disease in Turkey. Ann Rheum Dis. 2000;59:622\u20135.","journal-title":"Ann Rheum Dis"},{"key":"542_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(99)70333-1","volume":"135","author":"I Kon\u00e9-Paut","year":"1999","unstructured":"Kon\u00e9-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, et al. Familial aggregation in Beh\u00e7et\u2019s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135:89\u201393.","journal-title":"J Pediatr"},{"key":"542_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Beh\u00e7et\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54:213\u201320.","journal-title":"Tissue Antigens"},{"key":"542_CR5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","volume":"100","author":"S Ohno","year":"1982","unstructured":"Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Beh\u00e7et\u2019s disease. Arch Ophthalmol. 1982;100:1455\u20138.","journal-title":"Arch Ophthalmol"},{"key":"542_CR6","first-page":"1383","volume":"2","author":"S Ono","year":"1973","unstructured":"Ono S, Aoki K, Sugiura S, Nakayama E, Itakura K. Letter: HL-A5 and Beh\u00e7et\u2019s disease. Lancet. 1973;2:1383\u20134.","journal-title":"Lancet"},{"key":"542_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci. Nat Genet. 2010;42:703\u20136.","journal-title":"Nat Genet"},{"key":"542_CR8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet. 2010;42:698\u2013702.","journal-title":"Nat Genet"},{"key":"542_CR9","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/art.21060","volume":"52","author":"J Karasneh","year":"2005","unstructured":"Karasneh J, G\u00fcl A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Beh\u00e7et\u2019s disease. Arthritis Rheum. 2005;52:1836\u201342.","journal-title":"Arthritis Rheum"},{"key":"542_CR10","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar2695","volume":"11","author":"Y Fei","year":"2009","unstructured":"Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Beh\u00e7et\u2019s disease using a genome-wide association study. Arthritis Res Ther. 2009;11:R66.","journal-title":"Arthritis Res Ther"},{"key":"542_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2009.108571","volume":"69","author":"A Meguro","year":"2010","unstructured":"Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, et al. Genetics of Beh\u00e7et disease inside and outside the MHC. Ann Rheum Dis. 2010;69:747\u201354.","journal-title":"Ann Rheum Dis"},{"key":"542_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0039.2001.580202.x","volume":"58","author":"K Sano","year":"2001","unstructured":"Sano K, Yabuki K, Imagawa Y, Shiina T, Mizuki N, Ohno S, et al. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Beh\u00e7et\u2019s disease. Tissue Antigens. 2001;58:77\u201382.","journal-title":"Tissue Antigens"},{"key":"542_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0039.2008.01111.x","volume":"72","author":"Y Takemoto","year":"2008","unstructured":"Takemoto Y, Naruse T, Namba K, Kitaichi N, Ota M, Shindo Y, et al. Re-evaluation of heterogeneity in HLA-B*510101 associated with Beh\u00e7et\u2019s disease. Tissue Antigens. 2008;72:347\u201353.","journal-title":"Tissue Antigens"},{"key":"542_CR14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X","volume":"44","author":"A G\u00fcl","year":"2001","unstructured":"G\u00fcl A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. Evidence for linkage of the HLA-B locus in Beh\u00e7et\u2019s disease, obtained using the transmission disequilibrium test. Arthritis Rheum. 2001;44:239\u201340.","journal-title":"Arthritis Rheum"},{"key":"542_CR15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M Menthon de","year":"2009","unstructured":"de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61:1287\u201396.","journal-title":"Arthritis Rheum"},{"key":"542_CR16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","volume":"38","author":"M Takeno","year":"1995","unstructured":"Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, et al. Excessive function of peripheral blood neutrophils from patients with Beh\u00e7et\u2019s disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38:426\u201333.","journal-title":"Arthritis Rheum"},{"key":"542_CR17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/intimm\/7.2.223","volume":"7","author":"K Falk","year":"1995","unstructured":"Falk K, R\u00f6tzschke O, Takiguchi M, Gnau V, Stevanovi\u0107 S, Jung G, Rammensee HG. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Beh\u0107et\u2019s disease. Int Immunol. 1995;7:223\u20138.","journal-title":"Int Immunol"},{"key":"542_CR18","first-page":"2273","volume":"151","author":"K Pervin","year":"1993","unstructured":"Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Beh\u00e7et\u2019s disease. J Immunol. 1993;151:2273\u201382.","journal-title":"J Immunol"},{"key":"542_CR19","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.1830241103","volume":"24","author":"G Wildner","year":"1994","unstructured":"Wildner G, Thurau SR. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol. 1994;24:2579\u201385.","journal-title":"Eur J Immunol"},{"key":"542_CR20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2249.2000.01176.x","volume":"120","author":"S Kurhan-Yavuz","year":"2000","unstructured":"Kurhan-Yavuz S, Direskeneli H, Bozkurt N, Ozyazgan Y, Bavbek T, Kazokoglu H, et al. Anti-MHC autoimmunity in Beh\u00e7et\u2019s disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol. 2000;120:162\u20136.","journal-title":"Clin Exp Immunol"},{"key":"542_CR21","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1167\/iovs.09-4313","volume":"51","author":"M Takeuchi","year":"2010","unstructured":"Takeuchi M, Usui Y, Okunuki Y, Zhang L, Ma J, Yamakawa N, et al. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet\u2019s patients with uveitis. Invest Ophthalmol Vis Sci. 2010;51:3067\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"542_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","volume":"20","author":"C Vilches","year":"2002","unstructured":"Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 2002;20:217\u201351.","journal-title":"Annu Rev Immunol"},{"key":"542_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","volume":"132","author":"KS Campbell","year":"2011","unstructured":"Campbell KS, Purdy AK. Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology. 2011;132:315\u201325.","journal-title":"Immunology"},{"key":"542_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0167-5699(96)30054-V","volume":"17","author":"E Ciccone","year":"1996","unstructured":"Ciccone E, Grossi CE, Velardi A. Opposing functions of activatory T-cell receptors and inhibitory NK-cell receptors on cytotoxic T cells. Immunol Today. 1996;17:450\u20133.","journal-title":"Immunol Today"},{"key":"542_CR25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/rheumatology\/keh063","volume":"43","author":"G Saruhan-Direskeneli","year":"2004","unstructured":"Saruhan-Direskeneli G, Uyar FA, Cefle A, Onder SC, Eksioglu-Demiralp E, Kamali S, et al. Expression of KIR and C-type lectin receptors in Behcet\u2019s disease. Rheumatology (Oxford). 2004;43:423\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"542_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1399-0039.2007.00929.x","volume":"70","author":"D Middleton","year":"2007","unstructured":"Middleton D, Meenagh A, Sleator C, Gourraud PA, Ayna T, Tozkir H, et al. No association of KIR genes with Behcet\u2019s disease. Tissue Antigens. 2007;70:435\u20138.","journal-title":"Tissue Antigens"},{"key":"542_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0198-8859(98)00011-1","volume":"59","author":"Y Koumantaki","year":"1998","unstructured":"Koumantaki Y, Stavropoulos C, Spyropoulou M, Messini H, Papademetropoulos M, Giziaki E, et al. HLA-B*5101 in Greek patients with Beh\u00e7et\u2019s disease. Hum Immunol. 1998;59:250\u20135.","journal-title":"Hum Immunol"},{"issue":"2 Suppl 53","key":"542_CR28","first-page":"48","volume":"27","author":"A Arida","year":"2009","unstructured":"Arida A, Vaiopoulos G, Markomichelakis N, Kaklamanis P, Sfikakis PP. Are clusters of patients with distinct clinical expression present in Beh\u00e7et\u2019s disease? Clin Exp Rheumatol. 2009;27(2 Suppl 53):48\u201351.","journal-title":"Clin Exp Rheumatol"},{"key":"542_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1034\/j.1399-0039.1999.540307.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity DH, Wallace GR, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Beh\u00e7et\u2019s disease. Tissue Antigens. 1999;54:264\u201372.","journal-title":"Tissue Antigens"},{"key":"542_CR30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2230.2002.01060.x","volume":"27","author":"TI Kaya","year":"2002","unstructured":"Kaya TI, Dur H, Tursen U, Gurler A. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Beh\u00e7et\u2019s disease. Clin Exp Dermatol. 2002;27:498\u2013501.","journal-title":"Clin Exp Dermatol"},{"key":"542_CR31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/40.6.668","volume":"40","author":"A G\u00fcl","year":"2001","unstructured":"G\u00fcl A, Uyar FA, Inanc M, Ocal L, Tugal-Tutkun I, Aral O, et al. Lack of association of HLA-B*51 with a severe disease course in Beh\u00e7et\u2019s disease. Rheumatology (Oxford). 2001;40:668\u201372.","journal-title":"Rheumatology (Oxford)"},{"key":"542_CR32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/eye.2008.177","volume":"23","author":"L Krause","year":"2009","unstructured":"Krause L, K\u00f6hler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, et al. Ocular involvement is associated with HLA-B51 in Adamantiades-Beh\u00e7et\u2019s disease. Eye (Lond). 2009;23:1182\u20136.","journal-title":"Eye (Lond)"},{"issue":"3","key":"542_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0021-5155(01)00321-5","volume":"45","author":"M Nishiyama","year":"2001","unstructured":"Nishiyama M, Nakae K, Umehara T. A study of familial occurrence of Beh\u00e7et\u2019s disease with and without ocular lesions. Jpn J Ophthalmol. 2001;45(3):313\u20136.","journal-title":"Jpn J Ophthalmol"},{"issue":"4 Suppl 60","key":"542_CR34","first-page":"39","volume":"28","author":"T Kaburaki","year":"2010","unstructured":"Kaburaki T, Takamoto M, Numaga J, Kawashima H, Araie M, Ohnogi Y, Harihara S, Kuwata S, Takeuchi F. Genetic association of HLA-A*2601 with ocular Beh\u00e7et\u2019s disease in Japanese patients. Clin Exp Rheumatol. 2010;28(4 Suppl 60):39\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"542_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/ar3292","volume":"13","author":"EH Kang","year":"2011","unstructured":"Kang EH, Kim JY, Takeuchi F, Kim JW, Shin K, Lee EY, Lee YJ, Lee EB, Park MH, Song YW. Associations between the HLA-A polymorphism and the clinical manifestations of Behcet\u2019s disease. Arthritis Res Ther. 2011;13(2):49.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"542_CR36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1399-0039.1981.tb00687.x","volume":"17","author":"AU M\u00fcft\u00fco\u011flu","year":"1981","unstructured":"M\u00fcft\u00fco\u011flu AU, Yazici H, Yurdakul S, Pazarli H, Ozyazgan Y, T\u00fcz\u00fcn Y, Alta\u00e7 M, Yal\u00e7in B. Beh\u00e7et\u2019s disease: lack of correlation of clinical manifestations with HLA antigens. Tissue Antigens. 1981;17(2):226\u201330.","journal-title":"Tissue Antigens"},{"issue":"6 Suppl 36","key":"542_CR37","first-page":"46","volume":"22","author":"N Pipitone","year":"2004","unstructured":"Pipitone N, Boiardi L, Olivieri I, Cantini F, Salvi F, Malatesta R, et al. Clinical manifestations of Beh\u00e7et\u2019s disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol. 2004;22(6 Suppl 36):46\u201351.","journal-title":"Clin Exp Rheumatol"},{"key":"542_CR38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/0-306-48382-3_9","volume":"528","author":"I K\u00f6tter","year":"2003","unstructured":"K\u00f6tter I, Vonthein R, G\u00fcnaydin I, M\u00fcller C, Kanz L, Zierhut M, et al. Beh\u00e7et\u2019s disease in patients of German and Turkish origin\u2014a comparative study. Adv Exp Med Biol. 2003;528:53\u20138.","journal-title":"Adv Exp Med Biol"},{"key":"542_CR39","first-page":"413","volume":"89","author":"YM Chung","year":"1990","unstructured":"Chung YM, Yeh TS, Sheu MM, Chen MS, Wen MS, Tsai HY, et al. Behcet\u2019s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc. 1990;89:413\u20137.","journal-title":"J Formos Med Assoc"},{"key":"542_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1399-0039.1997.tb02835.x","volume":"50","author":"N Mizuki","year":"1997","unstructured":"Mizuki N, Ohno S, Ando H, Chen L, Palimeris GD, Stavropoulos-Ghiokas E, et al. A strong association between HLA-B*5101 and Beh\u00e7et\u2019s disease in Greek patients. Tissue Antigens. 1997;50:57\u201360.","journal-title":"Tissue Antigens"},{"key":"542_CR41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1034\/j.1399-0039.2001.057005457.x","volume":"57","author":"N Mizuki","year":"2001","unstructured":"Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Yoshida M, Onari K, et al. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Beh\u00e7et\u2019s disease. Tissue Antigens. 2001;57:457\u201362.","journal-title":"Tissue Antigens"},{"key":"542_CR42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjo.81.8.649","volume":"81","author":"DJ Kilmartin","year":"1997","unstructured":"Kilmartin DJ, Finch A, Acheson RW. Primary association of HLA-B51 with Beh\u00e7et\u2019s disease in Ireland. Br J Ophthalmol. 1997;81:649\u201353.","journal-title":"Br J Ophthalmol"},{"key":"542_CR43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1034\/j.1399-0039.1999.540605.x","volume":"54","author":"J Kera","year":"1999","unstructured":"Kera J, Mizuki N, Ota M, Katsuyama Y, Pivetti-Pezzi P, Ohno S, et al. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Beh\u00e7et\u2019s disease in Italian patients. Tissue Antigens. 1999;54:565\u201371.","journal-title":"Tissue Antigens"},{"key":"542_CR44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-0039.2004.00280.x","volume":"64","author":"I Pirim","year":"2004","unstructured":"Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C. HLA class I and class II genotyping in patients with Behcet\u2019s disease: a regional study of eastern part of Turkey. Tissue Antigens. 2004;64:293\u20137.","journal-title":"Tissue Antigens"},{"key":"542_CR45","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaro\u011flu IC, D\u00fcndar S, Kirazli S. Cytokines in Beh\u00e7et\u2019s disease. J Rheumatol. 1996;23:321\u20132.","journal-title":"J Rheumatol"},{"key":"542_CR46","first-page":"128","volume":"24","author":"B Turan","year":"1997","unstructured":"Turan B, Gallati H, Erdi H, G\u00fcrler A, Michel BA, Villiger PM. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bech\u00e7et\u2019s disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol. 1997;24:128\u201332.","journal-title":"J Rheumatol"},{"key":"542_CR47","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544\u20139.","journal-title":"J Rheumatol"},{"key":"542_CR48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","volume":"107","author":"N Yamashita","year":"1997","unstructured":"Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, et al. Role of gammadelta T lymphocytes in the development of Beh\u00e7et\u2019s disease. Clin Exp Immunol. 1997;107:241\u20137.","journal-title":"Clin Exp Immunol"},{"key":"542_CR49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","volume":"40","author":"LP Robertson","year":"2001","unstructured":"Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Beh\u00e7et\u2019s syndrome with infliximab. Rheumatology (Oxford). 2001;40:473\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"542_CR50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"PP Sfikakis","year":"2001","unstructured":"Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN. Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et\u2019s disease. Lancet. 2001;358:295\u20136.","journal-title":"Lancet"},{"key":"542_CR51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kep126","volume":"48","author":"S Iwata","year":"2009","unstructured":"Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, et al. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet\u2019s disease. Rheumatology (Oxford). 2009;48:1012\u20133.","journal-title":"Rheumatology (Oxford)"},{"key":"542_CR52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arcmed.2010.02.002","volume":"41","author":"Z Touma","year":"2010","unstructured":"Touma Z, Farra C, Hamdan A, Shamseddeen W, Uthman I, Hourani H, et al. TNF polymorphisms in patients with Beh\u00e7et disease: a meta-analysis. Arch Med Res. 2010;41:142\u20136.","journal-title":"Arch Med Res"},{"key":"542_CR53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2133.2006.07348.x","volume":"155","author":"A Akman","year":"2006","unstructured":"Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, et al. TNF-alpha gene 1031 T\/C polymorphism in Turkish patients with Beh\u00e7et\u2019s disease. Br J Dermatol. 2006;155:350\u20136.","journal-title":"Br J Dermatol"},{"key":"542_CR54","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.91.14.6259","volume":"91","author":"S Bahram","year":"1994","unstructured":"Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA. 1994;91:6259\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"542_CR55","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1073\/pnas.94.4.1298","volume":"94","author":"N Mizuki","year":"1997","unstructured":"Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Beh\u00e7et disease. Proc Natl Acad Sci USA. 1997;94:1298\u2013303.","journal-title":"Proc Natl Acad Sci USA"},{"key":"542_CR56","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1086\/302364","volume":"64","author":"M Ota","year":"1999","unstructured":"Ota M, Mizuki N, Katsuyama Y, Tamiya G, Shiina T, Oka A, et al. The critical region for Beh\u00e7et disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet. 1999;64:1406\u201310.","journal-title":"Am J Hum Genet"},{"key":"542_CR57","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 1998;279:1737\u201340.","journal-title":"Science"},{"key":"542_CR58","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7","volume":"42","author":"N Mizuki","year":"1999","unstructured":"Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Goto K, et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Beh\u00e7et\u2019s disease. Arthritis Rheum. 1999;42:1961\u20136.","journal-title":"Arthritis Rheum"},{"key":"542_CR59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s002510050656","volume":"49","author":"GR Wallace","year":"1999","unstructured":"Wallace GR, Verity DH, Delamaine LJ, Ohno S, Inoko H, Ota M, et al. MIC-A allele profiles and HLA class I associations in Beh\u00e7et\u2019s disease. Immunogenetics. 1999;49:613\u20137.","journal-title":"Immunogenetics"},{"key":"542_CR60","first-page":"3702","volume":"41","author":"N Mizuki","year":"2000","unstructured":"Mizuki N, Ota M, Yabuki K, Katsuyama Y, Ando H, Palimeris GD, et al. Localization of the pathogenic gene of Beh\u00e7et\u2019s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"542_CR61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.61.2.157","volume":"61","author":"R Cohen","year":"2002","unstructured":"Cohen R, Metzger S, Nahir M, Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Beh\u00e7et\u2019s disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis. 2002;61:157\u201360.","journal-title":"Ann Rheum Dis"},{"key":"542_CR62","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/art.20597","volume":"50","author":"H Yasuoka","year":"2004","unstructured":"Yasuoka H, Okazaki Y, Kawakami Y, Hirakata M, Inoko H, Ikeda Y, Kuwana M. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Beh\u00e7et\u2019s disease. Arthritis Rheum. 2004;50:3658\u201362.","journal-title":"Arthritis Rheum"},{"key":"542_CR63","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1468-3083.2009.03335.x","volume":"23","author":"YB Shang","year":"2009","unstructured":"Shang YB, Zhai N, Li JP, Han SX, Ren QS, Song FJ, et al. Study on association between polymorphism of HLA-DRB1 alleles and Beh\u00e7et\u2019s disease. J Eur Acad Dermatol Venereol. 2009;23:1419\u201322.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"542_CR64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.patbio.2008.09.012","volume":"57","author":"N Bennani","year":"2009","unstructured":"Bennani N, Atouf O, Benseffaj N, Brick C, Essakalli M. HLA polymorphism and Beh\u00e7et\u2019s disease in Moroccan population. Pathol Biol (Paris). 2009;57:403\u20139.","journal-title":"Pathol Biol (Paris)"},{"key":"542_CR65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.imlet.2004.03.017","volume":"93","author":"E Soto-Vega","year":"2004","unstructured":"Soto-Vega E, Garc\u00eda-Mu\u00f1oz R, Richaud-Patin Y, Z\u00fa\u00f1iga-Ramos J, Crisp\u00edn JC, D\u00edaz-Jouanen E, et al. Class I and class II MHC polymorphisms in Mexican patients with Beh\u00e7et\u2019s disease. Immunol Lett. 2004;93:211\u20135.","journal-title":"Immunol Lett"},{"key":"542_CR66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.1999.540308.x","volume":"54","author":"K Yabuki","year":"1999","unstructured":"Yabuki K, Ohno S, Mizuki N, Ando H, Tabbara KF, Goto K, et al. HLA class I and II typing of the patients with Beh\u00e7et\u2019s disease in Saudi Arabia. Tissue Antigens. 1999;54:273\u20137.","journal-title":"Tissue Antigens"},{"key":"542_CR67","first-page":"3332","volume":"33","author":"N Mizuki","year":"1992","unstructured":"Mizuki N, Inoko H, Mizuki N, Tanaka H, Kera J, Tsuiji K, et al. Human leukocyte antigen serologic and DNA typing of Beh\u00e7et\u2019s disease and its primary association with B51. Invest Ophthalmol Vis Sci. 1992;33:3332\u201340.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"542_CR68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-0039.1992.tb01953.x","volume":"40","author":"N Mizuki","year":"1992","unstructured":"Mizuki N, Ohno S, Tanaka H, Sugimura K, Seki T, Mizuki N, et al. Association of HLA-B51 and lack of association of class II alleles with Beh\u00e7et\u2019s disease. Tissue Antigens. 1992;40:22\u201330.","journal-title":"Tissue Antigens"},{"key":"542_CR69","first-page":"771","volume":"13","author":"SB Moore","year":"1986","unstructured":"Moore SB, O\u2019Duffy JD. Lack of association between Beh\u00e7et\u2019s disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol. 1986;13:771\u20133.","journal-title":"J Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0542-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:27Z","timestamp":1646843127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0542-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,25]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0542-4","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,25]]}}}